Invention Grant
- Patent Title: Quinolinyl and benzothiazolyl modulators
- Patent Title (中): 喹啉基和苯并噻唑基调节剂
-
Application No.: US12372699Application Date: 2009-02-17
-
Publication No.: US07960408B2Publication Date: 2011-06-14
- Inventor: Lawrence R. McGee , Jonathan B. Houze , Steven M. Rubenstein , Atsushi Hagiwara , Noboru Furukawa , Hisashi Shinkai
- Applicant: Lawrence R. McGee , Jonathan B. Houze , Steven M. Rubenstein , Atsushi Hagiwara , Noboru Furukawa , Hisashi Shinkai
- Applicant Address: US CA Thousand Oaks
- Assignee: Amgen Inc.
- Current Assignee: Amgen Inc.
- Current Assignee Address: US CA Thousand Oaks
- Agency: Jones Day
- Main IPC: A61K31/04
- IPC: A61K31/04
Abstract:
Compounds, compositions and methods are provided that are useful in the treatment or prevention of a condition or disorder mediated by PPARγ. In particular, the compounds of the invention modulate the function of PPARγ. The subject methods are particularly useful in the treatment and/or prevention of diabetes, obesity, hypercholesterolemia, rheumatoid arthritis and atherosclerosis.
Public/Granted literature
- US20090221635A1 QUINOLINYL AND BENZOTHIAZOLYL MODULATORS Public/Granted day:2009-09-03
Information query
